Replimune Group: Of This Current Report On Form 8k, Including Exhibit 99.1, Shall Not Be Deemed “filed” For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference In Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Expressly Stated By Specific Reference In Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Replimune Group, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***